Short Interest in Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Decreases By 66.7%

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the recipient of a large decrease in short interest in December. As of December 31st, there was short interest totalling 200 shares, a decrease of 66.7% from the December 15th total of 600 shares. Based on an average daily trading volume, of 800 shares, the days-to-cover ratio is presently 0.3 days.

Mosaic ImmunoEngineering Price Performance

Shares of Mosaic ImmunoEngineering stock traded down $0.03 on Monday, reaching $0.94. The company had a trading volume of 297 shares, compared to its average volume of 1,600. The firm has a market cap of $6.81 million, a price-to-earnings ratio of -6.27 and a beta of 0.27. The firm’s 50-day moving average price is $0.89 and its two-hundred day moving average price is $0.85. Mosaic ImmunoEngineering has a 1 year low of $0.10 and a 1 year high of $1.13.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.